Molecule Information
General Information of the Molecule (ID: Mol00751)
Name |
23S ribosomal RNA methyltransferase Erm (ERM39)
,Mycobacterium fortuitum
|
||||
---|---|---|---|---|---|
Synonyms |
erm(39); 23S ribosomal RNA methyltransferase Erm
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
erm(39)
|
||||
Sequence |
MSSAHHGRHENGQNFLRDRRVVGDIIRMVSHTTGPIVEIGAGDGALTLPLQRLGRPLTAI
EIDLHRARRLADRTTAEVVATDFLRYRLPRTPHVVVGNLPFHLTTAILRRLLHENGWTDA TLLVQWEVARRRAGVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTIQRRAE PLLPWADHRAYQALVHRVFTGRGRGLAQILRPHVHPRWLSTNGIHPSALPRALTAQQWVA LFEAAG Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
5 drug(s) in total
Clarithromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Mycobacterium fortuitum infection | [1] | |||
Resistant Disease | Mycobacterium fortuitum infection [ICD-11: 1B2Z.2] | |||
Resistant Drug | Clarithromycin | |||
Molecule Alteration | Missense mutation | Putative initiation codon GTG>CTG |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium peregrinum ATCC14467 | 43304 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Mueller-Hinton (MH) broth assay | |||
Mechanism Description | The erm genes are a diverse collection of methylases that add one or two methyl groups to the adenine at position 2058 (Escherichia coli numbering) of the 23S rRNA; this modification impairs the binding of macrolides to ribosomes, and thus reduces the inhibitory activity of these agents. |
Clindamycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Mycobacterium fortuitum infection | [1] | |||
Resistant Disease | Mycobacterium fortuitum infection [ICD-11: 1B2Z.2] | |||
Resistant Drug | Clindamycin | |||
Molecule Alteration | Missense mutation | Putative initiation codon GTG>CTG |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium peregrinum ATCC14467 | 43304 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Mueller-Hinton (MH) broth assay | |||
Mechanism Description | The erm genes are a diverse collection of methylases that add one or two methyl groups to the adenine at position 2058 (Escherichia coli numbering) of the 23S rRNA; this modification impairs the binding of macrolides to ribosomes, and thus reduces the inhibitory activity of these agents. |
Erythromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Mycobacterium fortuitum infection | [1] | |||
Resistant Disease | Mycobacterium fortuitum infection [ICD-11: 1B2Z.2] | |||
Resistant Drug | Erythromycin | |||
Molecule Alteration | Missense mutation | Putative initiation codon GTG>CTG |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium peregrinum ATCC14467 | 43304 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Mueller-Hinton (MH) broth assay | |||
Mechanism Description | The erm genes are a diverse collection of methylases that add one or two methyl groups to the adenine at position 2058 (Escherichia coli numbering) of the 23S rRNA; this modification impairs the binding of macrolides to ribosomes, and thus reduces the inhibitory activity of these agents. |
Quinupristin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Mycobacterium fortuitum infection | [1] | |||
Resistant Disease | Mycobacterium fortuitum infection [ICD-11: 1B2Z.2] | |||
Resistant Drug | Quinupristin | |||
Molecule Alteration | Missense mutation | Putative initiation codon GTG>CTG |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium peregrinum ATCC14467 | 43304 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Mueller-Hinton (MH) broth assay | |||
Mechanism Description | The erm genes are a diverse collection of methylases that add one or two methyl groups to the adenine at position 2058 (Escherichia coli numbering) of the 23S rRNA; this modification impairs the binding of macrolides to ribosomes, and thus reduces the inhibitory activity of these agents. |
Spiramycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Mycobacterium fortuitum infection | [1] | |||
Resistant Disease | Mycobacterium fortuitum infection [ICD-11: 1B2Z.2] | |||
Resistant Drug | Spiramycin | |||
Molecule Alteration | Missense mutation | Putative initiation codon GTG>CTG |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Mycobacterium peregrinum ATCC14467 | 43304 | ||
Experiment for Molecule Alteration |
DNA sequencing assay | |||
Experiment for Drug Resistance |
Mueller-Hinton (MH) broth assay | |||
Mechanism Description | The erm genes are a diverse collection of methylases that add one or two methyl groups to the adenine at position 2058 (Escherichia coli numbering) of the 23S rRNA; this modification impairs the binding of macrolides to ribosomes, and thus reduces the inhibitory activity of these agents. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.